Showing 176–200 of 278
Parent UnitedHealth Group (UNH) group FY2025 revenue $447.57bn (+11.8%); operating margin 4.2%; net income $12.06bn.
Optum: revenue $270.6bn (+7%), earnings from operations $9.5bn.
Parent Oracle (ORCL) group FY2026 revenue $67.36bn (+17.0%); operating margin 30.6%; net income $17.09bn.
Figures cover the whole listed group, not this business alone.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
FY2025 revenue SEK 73.4m (-8.7%); net loss SEK 21.9m.
EBITDA SEK -15.9m; raised about SEK 52m in a rights issue.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
FY2025 revenue £223.9m (+22.2%); operating margin -69.4%; net loss £145.2m.
No debt; £302.8m cash.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
FY2026 revenue $11.48bn (+24.5%); operating margin 6.1%; net income $307.0m.
Cash $7.91bn; debt $1.77bn.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
FY2025 revenue €17.83bn (-1.0%); operating margin 8.0%; net income €895.0m.
Net debt €5.29bn.
FY2026 revenue $480.6m (+14.0%); operating margin -1.4%; net income $2.3m.
Cash $73.8m; debt $100.1m.
Listed (1833.HK).
Latest full-year results not yet captured by HSH.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Listed (PINC).
Latest full-year results not yet captured by HSH.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
FY2026 revenue A$261.7m (+22.9%); underlying EBIT margin 74.9%; net income A$265.3m.
Statutory NPAT A$265.3m includes investment gain; underlying NPAT A$144.7m (+24.1%).
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.